Shaoyi Jiang

An important challenge in many applications is the prevention of unwanted nonspecific biomolecular and microorganism attachment on surfaces. To address this challenge, our goals are twofold. First, we strive to provide a fundamental understanding of nonfouling mechanisms at the molecular level. Second, we aim to develop biocompatible materials based on the molecular principles learned. As a result, we have shown that zwitterionic materials and surfaces are highly resistant to nonspecific protein adsorption and microorganism attachment from complex media. With zwitterionic coatings, hydrogels or nanoparticles, results show no capsule formation upon subcutaneous implantation in mice for one year, expansion of hematopoietic stem and progenitor cells (HSPCs) without differentiation, no anti-coagulants needed for artificial lungs in sheep, no antibodies generated against zwitterionic polymers, and environmentally benign marine coatings. Unlike poly(ethylene glycol) (PEG), there exist diversified zwitterionic molecular structures to accommodate various properties and applications. Furthermore, zwitterionic materials are super-hydrophilic while their PEG counterparts are amphiphilic. Currently, we are integrating immunology into our biomaterials research and translating our biomaterials to applications ranging from cancer vaccine to precision medicine.

Shaoyi Jiang joined the Meinig School of Biomedical Engineering at Cornell as the Robert Langer ’70 Family and Friends Professor in June 2020. Before Cornell, he was the Boeing-Roundhill Professor of Engineering in the Department of Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle. He received his Ph.D. degree in chemical engineering from Cornell University in 1993. He was a postdoctoral fellow at the University of California, Berkeley between 1993 and 1994 and a research fellow at California Institute of Technology between 1994 and 1996 both in chemistry. He is currently a member of the National Academy of Inventors, a fellow of the American Association for the Advancement of Science (AAAS), a fellow of the American Institute of Chemical Engineers (AIChE), a fellow of the American Institute for Medical and Biological Engineering (AIMBE), an executive editor for Langmuir and an associate editor for Science Advances. He received the Braskem Award for Excellence in Materials Engineering and Science, AIChE (2017). His research focuses on biomaterials and drug delivery, particularly highly biocompatible zwitterionic materials and low-immunogenic / targeted drug delivery carriers.

• Time: 11:00 AM
• Location: 206 Furnas Hall